See more : TGC Ventures International, Inc. (TGVN) Income Statement Analysis – Financial Results
Complete financial analysis of Optimi Health Corp. (OPTI.CN) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Optimi Health Corp., a leading company in the Agricultural Farm Products industry within the Consumer Defensive sector.
- Gencor Industries, Inc. (GENC) Income Statement Analysis – Financial Results
- AGNC Investment Corp. (AGNCL) Income Statement Analysis – Financial Results
- Nymox Pharmaceutical Corporation (NYMXF) Income Statement Analysis – Financial Results
- Beijing Qingyun Technology Co., Ltd. (688316.SS) Income Statement Analysis – Financial Results
- Canal Capital Corporation PFD EXCH $1.30 (COWPP) Income Statement Analysis – Financial Results
Optimi Health Corp. (OPTI.CN)
About Optimi Health Corp.
Optimi Health Corp. develops an integrated functional mushroom brand that focuses on the health and wellness food markets in Canada. The company also focuses on the cultivation, extraction, processing, and distribution of strains of functional mushroom. It offers a range of fungi varieties, which include Lions Mane, Reishi, Turkey Tail, Chaga, and Cordyceps. The company was formerly known as 1251418 BC Ltd. and changed its name to Optimi Health Corp. in August 2020. Optimi Health Corp. was incorporated in 2020 and is headquartered in Vancouver, Canada.
| Metric | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Revenue | 181.09K | 80.72K | 0.00 | 0.00 |
| Cost of Revenue | 338.12K | 26.80K | 47.12K | 5.43K |
| Gross Profit | -157.04K | 53.92K | -47.12K | -5.43K |
| Gross Profit Ratio | -86.72% | 66.80% | 0.00% | 0.00% |
| Research & Development | 152.15K | 133.24K | 240.92K | 0.00 |
| General & Administrative | 3.56M | 4.90M | 3.69M | 237.37K |
| Selling & Marketing | 374.17K | 2.11M | 2.08M | 246.06K |
| SG&A | 3.93M | 7.02M | 5.77M | 161.14K |
| Other Expenses | 0.00 | 293.60K | 47.12K | 0.00 |
| Operating Expenses | 4.22M | 7.44M | 6.06M | 161.14K |
| Cost & Expenses | 4.56M | 7.47M | 6.06M | 166.57K |
| Interest Income | 136.41K | 66.94K | 55.04K | 7.91K |
| Interest Expense | 43.71K | 27.99K | 19.18K | 2.66K |
| Depreciation & Amortization | 729.56K | 293.60K | 47.12K | 5.43K |
| EBITDA | -4.42M | -7.03M | -5.95M | -161.14K |
| EBITDA Ratio | -2,441.53% | -8,708.50% | 0.00% | 0.00% |
| Operating Income | -4.38M | -7.32M | -6.00M | -166.57K |
| Operating Income Ratio | -2,419.07% | -9,072.23% | 0.00% | 0.00% |
| Total Other Income/Expenses | -813.93K | -27.99K | 35.85K | -2.66K |
| Income Before Tax | -5.19M | -7.35M | -6.02M | -169.22K |
| Income Before Tax Ratio | -2,868.54% | -9,106.91% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | 27.99K | 19.18K | 5.00 |
| Net Income | -5.19M | -7.38M | -6.04M | -169.22K |
| Net Income Ratio | -2,868.54% | -9,141.59% | 0.00% | 0.00% |
| EPS | -0.06 | -0.09 | -0.09 | 0.00 |
| EPS Diluted | -0.06 | -0.09 | -0.09 | 0.00 |
| Weighted Avg Shares Out | 86.98M | 77.94M | 69.87M | 68.71M |
| Weighted Avg Shares Out (Dil) | 86.98M | 77.94M | 69.87M | 68.71M |
Source: https://incomestatements.info
Category: Stock Reports